= Share Structure - Updated 10/21/2013=
| Market Value || $1,873,462 || Updated 09/13/2013 |
| Shares Outstanding || || Updated 11/22/2013 |
| Float || 1,034,937,898 || Updated 11/22/2013 |
| Authorized Shares || 2,900,000,000 || Updated 11/22/2013 |
| Restricted Shares || 15,341,495 || Updated 10/21/2013 |
= Officers/Directors =
Amanda Segersten_Secretary_Vice President
Robert Segersten_President of Solos Endoscopy = Business Summary =
Robert Segersten, President Treasurer and Director: Mr. Segersten founded Woodbine Optical Corporation in 1991 in order to produce OEM video cameras for the medical marketplace. The company quickly added light sources, video couplers and relay lens to its product offering. Woodbine procured large OEM contracts from companies like Bircher Medical, Olympus, and ConMed. His relationship with Bircher Medical allowed Woodbine the opportunity to acquire the Solos Endoscopy Video division of Bircher. He successfully merged Solos into Woodbine and renamed the company - Solos Endoscopy capitalizing on the strong brand recognition of Solos. He grew the company to approximately $3 million in sales, at which time he was approached by EndoImage and sold Solos in 1994. He stayed on as President until 1996. He remained an advisor to the company until he reacquired ownership in 2000. He is a graduate of Bates College and received his law degree from Boston University.
Amanda Segersten_Vice President of Solos Endoscopy
Amanda Segersten attended Johnson and Wales University and has been employed by Solos Endoscopy since 2000.
Fred Schiemann_CFO of Solos Endoscopy
Fred Schiemann previously served as the Chief Financial Officer of Xtreme Oil & Gas, Inc. Prior to that, he has held CFO positions in several corporations and currently serves as Treasurer of Biz2Biz.com. His educational background includes an undergraduate degree from the University of Illinois, Chicago Circle Campus as well as an MBA in taxation from Golden Gate University, Sacramento campus. During his years of practice, he has been involved with many public registrations and structuring of mergers and acquisitions. His current practice includes an emphasis on administration and consulting to small and micro-cap public companies.
Solos Endoscopy, Inc. develops and markets technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment, and management of medical conditions. It primarily offers rigid endoscopes, hand held surgical instruments, and video equipment for the minimally invasive surgery market. The company's products include digital imaging systems; three-chip and one-chip camera systems, and three-chip cameras; cameras and accessories; rigid scopes comprising laparoscopes, operative scopes, cystoscopes, and scope trays; and endoscopic instruments, such as dissectors, graspers, scissors, needle holders, fan retractors, cautery instruments, insufflation needles, and clip applying forceps. Its products also comprise laparoscopic instruments, including general surgery, lymphadenectomy, gynecology, and thorascopy instruments; trocar and cannula sets, cannulas, trocars, reducer sleeves, and seals; monitors and video carts; video equipment and accessories; illumination instruments, such as fiber optic cables, light port adapters, light sources, and replacement lamps; and insufflators. In addition, Solos offers ENT products for tymplanoplasty, endoscopic sinus surgery, and septorhinoplasty; bariatric instruments; and insulated and non-insulated handles. It markets its products to hospitals, surgery centers, and physician offices through direct sales and it's Web site. The company was formerly known as ViaDux Health, Inc. and changed its name to Solos Endoscopy, Inc. in March 2006. Solos Endoscopy was founded in 1986 and is based in Boston, Massachusetts.
= Company =
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a healthcare technology company that develops and markets technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. The Company has several dozen products, mainly rigid endoscopes, hand held surgical instruments and video equipment for the minimally invasive surgery market, all of which can be found on its website at: www.solosendoscopy.com. The Company markets its products to hospitals, surgery centers and physician offices.
Additional information on its FDA approved products is available on the Company's website at: www.solosendoscopy.com.
65 Sprague Street
Boston, MA 02136
The office is approximately 6,000 square feet.
Investor Relations Phone: 1-617-360-9719
Pacific Stock Transfer
4045 South Spencer Street, Ste. 403
Las Vegas, NV 89119
Registered Under Exchange Act: Yes
Regulatory Authority: Security Exchange Commission (SEC)
= Press Releases =
Solos Endoscopy and TUV SUD America Schedule Stage 2 ISO 13485 Audit for August 16, 2013
Solos Endoscopy and TUV SUD America Schedule Stage 1 ISO 13485 Audit for February 26, 2013
Solos Endoscopy, Inc. ISO 13485 Certification & CE Mark Project Schedule - MARCH
= Latest Filings = Year end is December 31st. Quarterly filings are due 45 days after the end of each quarter:
Q1 Jan-Mar 10-Q due May 15th
Q2 Apr-Jun 10-Q due Aug 15th
Q3 Jul-Sep 10-Q due Nov 15th
Q4 Oct-Dec 10-K due Mar 30th (90 days allowed for Q4 which is included in the Annual Report)
= President's Letter/ Information=